Skip to main content

Table 1 Clinical and Laboratory Characteristics of Patients with Type 2 Diabetic Nephropathy

From: Smoking, oxidative stress and inflammation: Impact on resting energy expenditure in diabetic nephropathy

Parameter Non-smokers Mean ± SD or N (%) Smokers Mean ± SD or N (%)
N 24 11
Age (y) 69.1 ± 7.0 61.5 ± 9.3 *
Males/Females 24/0 11/0
Race White/Black 19/5 9/2
Weight (kg) 97.8 ± 16.8 102.5 ± 23.4
BMI (kg/m2) 32.6 ± 4.9 32.6 ± 6.6
Serum albumin (g/dL) 3.8 ± 0.33 3.63 ± 0.30
Serum Creatinine (mg/dL) 2.75 ± 1.21 1.80 ± 0.74 *
BUN (mg/dL) 46.5 ± 25.6 38.3 ± 21.8
Hemoglobin (g/dL) 13.3 ± 1.6 13.5 ± 2.4
24 hour urine protein (g/d) 3393 ± 2522 4423 ± 4385
Iothalamate clearance (GFR) (mL/min/1.73 m2) 28.9 ± 13.8 47.2 ± 34.8 *
Duration of diabetes (yr) 15.7 ± 9.1 13.3 ± 9.0
Insulin use 15 (63%) 6 (55%)
Hemoglobin A1C (%) 7.57 ± 2.02 8.98 ± 2.93
Waist/Hip Ratio 1.00 ± 0.07 1.04 ± 0.07
Antihypertensive medications 4.3 ± 1.6 3.9 ± 1.9
ACE inhibitor or Angiotensin receptor blocker use 21 (88%) 8 (73%)
Total Cholesterol (mg/dL) 184 ± 51 223 ± 87
LDL Cholesterol (mg/dL) 100 ± 44 116 ± 24
HDL Cholesterol (mg/dL) 42 ± 11.1 46 ± 11.4
Vascular Disease (coronary, cerebrovascular or peripheral vascular disease) 17 (71%) 7 (64%)
  1. * p < 0.05